Low risk, very high reward I think, I rate monkey tox passing and FDA lifting hold a major catalyst for the company success
Optimists could see things starting to align...
- Monkeys suddenly available and we got in at a good time - Monkey Data crucial to US partner ticking off on deal, one would think - monkey data out pre trial results - Cleaning up share register - Competitor stumbling - ANP starting to look compelling to a partner, more so every day as we approach mid 2024
Are there enough boxes being ticked? time will tell
ANP Price at posting:
6.1¢ Sentiment: Buy Disclosure: Held
